A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Phase 3
330
about 1.4 years
18–85
32 sites in AL, AR, AZ +14
What this study is about
Researchers are testing whether CYB003, an adjunctive treatment to psychological support, can help people with major depressive disorder. The trial will last for 514 days and involve approximately 330 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Psychological Support
- 2.Take CYB003
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Montgomery-Asberg Depression Scale (MADRS)
Secondary: The Beck Depression Inventory - Second Edition (BDI-II), The Generalized Anxiety Disorder 7-Item Scale (GAD-7), The Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form (Q-LES-Q-SF)
Psychiatry / Mental Health